Ultragenyx Pharmaceutical (RARE)
(Delayed Data from NSDQ)
$41.77 USD
+0.32 (0.77%)
Updated Jun 6, 2024 04:00 PM ET
After-Market: $41.75 -0.02 (-0.05%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -1.63 |
EPS Last Quarter | -2.03 |
Last EPS Surprise | -18.02% |
ABR | 1.24 |
Earnings ESP
|
2.06% |
---|---|
Current Year | -6.49 |
Next Year | -5.05 |
EPS (TTM) | -8.03 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 124.24M | 132.77M | 512.63M | 601.37M |
# of Estimates | 9 | 9 | 9 | 9 |
High Estimate | 130.00M | 137.60M | 525.25M | 653.56M |
Low Estimate | 120.00M | 121.90M | 501.50M | 544.20M |
Year ago Sales | 108.31M | 98.05M | 434.25M | 512.63M |
Year over Year Growth Est. | 14.71% | 35.41% | 18.05% | 17.31% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.63 | -1.51 | -6.49 | -5.05 |
# of Estimates | 11 | 9 | 12 | 11 |
Most Recent Consensus | -1.88 | -1.74 | -7.03 | -4.40 |
High Estimate | -1.32 | -1.22 | -5.76 | -2.23 |
Low Estimate | -1.89 | -1.74 | -7.28 | -6.17 |
Year ago EPS | -2.25 | -2.23 | -8.25 | -6.49 |
Year over Year Growth Est. | 27.56% | 32.29% | 21.33% | 22.21% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 4 | 2 | 5 |
Down Last 7 Days | 0 | 0 | 0 | 3 |
Down Last 30 Days | 0 | 0 | 0 | 3 |
Down Last 60 Days | 4 | 3 | 8 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.63 | -1.51 | -6.49 | -5.05 |
7 Days Ago | -1.63 | -1.51 | -6.49 | -4.92 |
30 Days Ago | -1.63 | -1.51 | -6.49 | -4.92 |
60 Days Ago | -1.56 | -1.50 | -6.34 | -5.10 |
90 Days Ago | -1.56 | -1.50 | -6.37 | -5.03 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.60 | -1.51 | -6.36 | -5.00 |
Zacks Consensus Estimate | -1.63 | -1.51 | -6.49 | -5.05 |
Earnings ESP | 2.06% | 0.00% | 2.02% | 1.07% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -2.03 | -1.52 | -2.23 | -2.25 | NA |
Estimate | -1.72 | -1.65 | -2.08 | -2.11 | NA |
Difference | -0.31 | 0.13 | -0.15 | -0.14 | -0.12 |
Surprise | -18.02% | 7.88% | -7.21% | -6.64% | -6.00% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more